SCHEMBL7501362

SCHEMBL7501362

CCOC(=O)CC(C[N+](=O)[O-])C(CO[Si](C)(C)C(C)(C)C)NC(=O)OC(C)(C)C

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
HTT P42858 1/20 0.37
TP53 P04637 1/20 0.34
CA1 P00915 2/20 0.33
CA2 P00918 2/20 0.33
CA7 P43166 2/20 0.33
GSTP1 P09211 1/20 0.33
GSTM2 P28161 1/20 0.33
TSHR P16473 1/20 0.32
CTSK P43235 2/20 0.32
SMN1; SMN2 Q16637 1/20 0.31
CYP2D6 P10635 1/20 0.31
CA4 P22748 1/20 0.30
CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7501377 1.00 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL7501369 1.00 CYP1A2 (0.37) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL7505047 0.85 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL7505039 0.85 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL7505042 0.85 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL7500394 0.83 CYP1A2 (0.38) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL7501049 0.83 CYP1A2 (0.41) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL19200954 0.79 CYP1A2 (0.43) CYP1A2CYP2C9CYP2C19HTTTP53
SCHEMBL16317020 0.72 CA1 (0.58) CA1CA2CA7TSHRCTSK
SCHEMBL16690443 0.72 CYP2D6 (0.47) HTTCA1CA2CA7TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0723545-B1 QUINOLIZINONE TYPE COMPOUNDS ABBOTT LAB (US) 2002-05-08 EP disclosed
US-5726182-A TREATMENT OF BACTERIAL INFECTIONS ABBOTT LABORATORIES (US) 1998-03-10 US disclosed
US-5599816-A BACTERICIDE ABBOTT LABORATORIES (US) 1997-02-04 US disclosed
US-5580872-A ADMINISTERING IN THE TREATMENT OF BACTERIAL INFECTIONS ABBOTT LABORATORIES (US) 1996-12-03 US disclosed
WO-1995010519-A1 QUINOLIZINONE TYPE COMPOUNDS ABBOTT LABORATORIES (US) 1995-04-20 WO disclosed